EdgarLookup

TC BioPharm (Holdings) plc — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TC BioPharm (Holdings) plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2024 Mar 31, 2024 (3.32M) May 15, 2024
Q1 2024 Mar 31, 2023 (634,911) May 15, 2024

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2024 Mar 31, 2024 (3.44M) May 15, 2024
Q1 2024 Mar 31, 2023 (4.17M) May 15, 2024